Viewing Study NCT02955160


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-01-07 @ 5:32 PM
Study NCT ID: NCT02955160
Status: COMPLETED
Last Update Posted: 2018-09-11
First Post: 2016-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module